相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men
Hannes Hagstrom et al.
GUT (2018)
Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016
Craig M. Hales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases
Luc Rochette et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Relationship between insulin resistance, hs-CRP, and body fat and serum osteoprotegerin/RANKL in prediabetic patients
Oktay Bilgir et al.
MINERVA ENDOCRINOLOGICA (2018)
The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans
Giuseppe Daniele et al.
ACTA DIABETOLOGICA (2018)
Circulating osteoprotegerin in postmenopausal osteoporotic women: marker of impaired glucose regulation or impaired bone metabolism
Margarita Mashavi et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)
Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle
Eleonora Poggiogalle et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
Peng Duan et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2017)
Wnt/β-catenin signaling in osteoblasts regulates global energy metabolism
Qianqian Yao et al.
BONE (2017)
Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene
Yilin Hao et al.
CARDIOVASCULAR RESEARCH (2016)
Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults
M. Monseu et al.
DIABETES & METABOLISM (2016)
Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case-control study in China
Yixin Niu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children
Meltem Erol et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL (2016)
The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity
Lucia Pacifico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Osteoprotegerin in Cardiometabolic Disorders
C. Perez de Ciriza et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study
Yixin Niu et al.
BMC ENDOCRINE DISORDERS (2015)
Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity
Clarisse Noel Ayina Ayina et al.
DIABETOLOGY & METABOLIC SYNDROME (2015)
Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?
G. Targher et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
Mei Yang et al.
PLOS ONE (2015)
Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification
Carmen Perez de Ciriza et al.
CLINICAL BIOCHEMISTRY (2014)
Osteoprotegerin in Cardiovascular Disease: Ally or Enemy?
Giacomo Buso et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus
S. Tavintharan et al.
DIABETES & VASCULAR DISEASE RESEARCH (2014)
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes
Stella Bernardi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
The Relation Between Carotid Intima Media Thickness and Serum Osteoprotegerin Levels in Nonalcoholic Fatty Liver Disease
Teslime Ayaz et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2014)
OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice
Munehisa Shimamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso et al.
PLOS MEDICINE (2014)
Nonalcoholic fatty liver disease and the heart in children and adolescents
Lucia Pacifico et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The role of osteoprotegerin in cardiovascular disease
Martina Montagnana et al.
ANNALS OF MEDICINE (2013)
The association of insulin resistance with serum osteoprotegerin in obese adolescents
Joanna Suliburska et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2013)
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
Stefan Kiechl et al.
NATURE MEDICINE (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance
Eoin P. O'Sullivan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease
Lucia Pacifico et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children
P. E. Pardee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Review article: non-alcoholic fatty liver disease and osteoporosis - clinical and molecular crosstalk
Y. Yilmaz
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome
Baris Akinci et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Circulating osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction
Carmen Emanuela Pepene et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Effects of RANKL on the thymic medulla
Izumi Ohigashi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects
David T. Ashley et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Naoki Kumashiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Association of Serum Osteoprotegerin With Left Ventricular Mass in African-American Adults With Hypertension
Amit Noheria et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
Shreenidhi M. Venuraju et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women
Iraj Nabipour et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease
Yusuf Yilmaz et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Pathophysiological roles of osteoprotegerin (OPG)
Penny Reid et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2009)
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Andreas Leibbrandt et al.
YEAR IN IMMUNOLOGY 2008 (2008)
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Brendan F. Boyce et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Determinants of endothelial function in a cohort of patients with peripheral artery disease
J. Golledge et al.
CARDIOLOGY (2008)
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice
Sean Morony et al.
CIRCULATION (2008)
Relationship of elevated osteoprotegerin with insulin resistance, CRP and TNF-α levels in men with type 2 diabetes
Subhashini Yaturu et al.
CYTOKINE (2008)
Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes
Baris Akinci et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy
A. Jorsal et al.
DIABETOLOGIA (2008)
Causes and Metabolic Consequences of Fatty Liver
Norbert Stefan et al.
ENDOCRINE REVIEWS (2008)
Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals:: results from both cross-sectional and interventional study
Marie-Helene Gannage-Yared et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway
Estelle Chamoux et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women
Betul Ugur-Altun et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
Expression and regulation of osteoprotegefin in adipose tissue
Juan-Ji An et al.
YONSEI MEDICAL JOURNAL (2007)
Plasma osteoprotegerin levels in the general population - Relation to indices of left ventricular structure and function
Torbjorn Omland et al.
HYPERTENSION (2007)
Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin
Ping Olesen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases
M. Baud'huin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
Karin Loser et al.
NATURE MEDICINE (2006)
Assessment of a serum assay for quantification of abdominal aortic calcification
Paula Clancy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Receptor activator of NF-κB ligand and osteoprotegerin regulate proinflammatory cytokine production in mice
Kenta Maruyama et al.
JOURNAL OF IMMUNOLOGY (2006)
Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population
Marie-Helene Gannage-Yared et al.
CLINICAL ENDOCRINOLOGY (2006)
Apoptosis in alcoholic and nonalcoholic steatohepatitis
AE Feldstein et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity
B Ugur-Altun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-κB ligand in Monckeberg's sclerosis and atherosclerosis
M Schoppet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis
J Golledge et al.
STROKE (2004)
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
P Collin-Osdoby
CIRCULATION RESEARCH (2004)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
An integrated physical map of 8q22-q24:: Use in positional cloning and deletion analysis of Langer-Giedion syndrome
MJ Hilton et al.
GENOMICS (2001)
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis
H Min et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
